Cargando…

Survival nomograms for stage III colorectal cancer

The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously. We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy. A total of 620 consecutive patients with stage III CRC who underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenglong, Pei, Qian, Zhu, Hong, Tan, Fengbo, Zhou, Zhongyi, Zhou, Yuan, Li, Yuqiang, Pei, Haiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310595/
https://www.ncbi.nlm.nih.gov/pubmed/30544384
http://dx.doi.org/10.1097/MD.0000000000013239
_version_ 1783383469286490112
author Li, Chenglong
Pei, Qian
Zhu, Hong
Tan, Fengbo
Zhou, Zhongyi
Zhou, Yuan
Li, Yuqiang
Pei, Haiping
author_facet Li, Chenglong
Pei, Qian
Zhu, Hong
Tan, Fengbo
Zhou, Zhongyi
Zhou, Yuan
Li, Yuqiang
Pei, Haiping
author_sort Li, Chenglong
collection PubMed
description The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously. We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy. A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248). Clinicopathological factors were collected and analyzed. On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms. The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots. An external cohort of 248 patients was used to validate the nomograms. Furthermore, nomogram performance was compared with the performance of T and N stage stratification. Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS. Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.734 [95% CI, 0.691–0.779] for OS and 0.699 [95% CI, 0.657–0.740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort. Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC. We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance.
format Online
Article
Text
id pubmed-6310595
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63105952019-01-14 Survival nomograms for stage III colorectal cancer Li, Chenglong Pei, Qian Zhu, Hong Tan, Fengbo Zhou, Zhongyi Zhou, Yuan Li, Yuqiang Pei, Haiping Medicine (Baltimore) Research Article The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously. We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy. A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248). Clinicopathological factors were collected and analyzed. On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms. The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots. An external cohort of 248 patients was used to validate the nomograms. Furthermore, nomogram performance was compared with the performance of T and N stage stratification. Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS. Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.734 [95% CI, 0.691–0.779] for OS and 0.699 [95% CI, 0.657–0.740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort. Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC. We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance. Wolters Kluwer Health 2018-12-10 /pmc/articles/PMC6310595/ /pubmed/30544384 http://dx.doi.org/10.1097/MD.0000000000013239 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Li, Chenglong
Pei, Qian
Zhu, Hong
Tan, Fengbo
Zhou, Zhongyi
Zhou, Yuan
Li, Yuqiang
Pei, Haiping
Survival nomograms for stage III colorectal cancer
title Survival nomograms for stage III colorectal cancer
title_full Survival nomograms for stage III colorectal cancer
title_fullStr Survival nomograms for stage III colorectal cancer
title_full_unstemmed Survival nomograms for stage III colorectal cancer
title_short Survival nomograms for stage III colorectal cancer
title_sort survival nomograms for stage iii colorectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310595/
https://www.ncbi.nlm.nih.gov/pubmed/30544384
http://dx.doi.org/10.1097/MD.0000000000013239
work_keys_str_mv AT lichenglong survivalnomogramsforstageiiicolorectalcancer
AT peiqian survivalnomogramsforstageiiicolorectalcancer
AT zhuhong survivalnomogramsforstageiiicolorectalcancer
AT tanfengbo survivalnomogramsforstageiiicolorectalcancer
AT zhouzhongyi survivalnomogramsforstageiiicolorectalcancer
AT zhouyuan survivalnomogramsforstageiiicolorectalcancer
AT liyuqiang survivalnomogramsforstageiiicolorectalcancer
AT peihaiping survivalnomogramsforstageiiicolorectalcancer